Relmada Therapeutics, Inc. (RLMD) NASDAQ

3.92

-0.145(-3.57%)

Updated at December 04 03:28PM

Currency In USD

Valuation

Market Cap15.69M
Enterprise Value11.83M
P/E Ratio-1.91
PEG Ratio-0.17
Price/Sales Ratio0
Price/Book Ratio8.14
Enterprise/Revenue0
Enterprise/EBITDA-4.07

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-3.21
Return On Equity-2.23

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-83.89M
Net Income-79.98M
Diluted EPS-2.65

Balance Sheet

Total Cash13.89M
Total Cash/Share0.62
Total Debt0
Total Debt/Equity0
Current Ratio4.11
Book Value Per Share0.48

Price History

52-Week Change520.63
52-Week High5.12
52-Week Low0.24
Moving Average 50 Days2.82
Moving Average 200 Days1.17

Statistics

Average Volume1M
Shares Outstanding73.33M
% Held by Institutions23.32

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:4
Last Split DateSeptember 30, 2019